(12) evaluated salivary duct carcinoma specimens from 113 patients and found that 26% of the samples had positive PD-L1 expression (TPS≥1%), but the authors did not analyze the association between PD-L1 expression and clinicopathological variables. This evidence concerns the gene CD274 and salivary duct carcinoma.